584 related articles for article (PubMed ID: 27568843)
1. Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs.
Piccioli A; Donati F; Giacomo GD; Ziranu A; Careri S; Spinelli MS; Giannini S; Giannicola G; Perisano C; Maccauro G
Injury; 2016 Oct; 47 Suppl 4():S22-S28. PubMed ID: 27568843
[TBL] [Abstract][Full Text] [Related]
2. Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty.
Scoccianti G; Frenos F; Beltrami G; Campanacci DA; Capanna R
Injury; 2016 Oct; 47 Suppl 4():S11-S16. PubMed ID: 27523624
[TBL] [Abstract][Full Text] [Related]
3. Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery.
Donati F; Di Giacomo G; D'Adamio S; Ziranu A; Careri S; Rosa M; Maccauro G
Biomed Res Int; 2016; 2016():9079041. PubMed ID: 27642605
[TBL] [Abstract][Full Text] [Related]
4. Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.
Zhang C; Hu J; Zhu K; Cai T; Ma X
Int Orthop; 2018 Apr; 42(4):927-938. PubMed ID: 29427125
[TBL] [Abstract][Full Text] [Related]
5. What is the Cumulative Incidence of Revision Surgery and What Are the Complications Associated With Stemmed Cementless Nonextendable Endoprostheses in Patients 18 Years or Younger With Primary Bone Sarcomas About the Knee.
El Ghoneimy AM; Shehab AM; Farid N
Clin Orthop Relat Res; 2022 Jul; 480(7):1329-1338. PubMed ID: 35171125
[TBL] [Abstract][Full Text] [Related]
6. LUMiC
Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
[TBL] [Abstract][Full Text] [Related]
7. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study.
Wafa H; Grimer RJ; Reddy K; Jeys L; Abudu A; Carter SR; Tillman RM
Bone Joint J; 2015 Feb; 97-B(2):252-7. PubMed ID: 25628291
[TBL] [Abstract][Full Text] [Related]
8. SILVER COATED PROSTHESIS IN ONCOLOGICAL LIMB SALVAGE SURGERY REDUCE THE INFECTION RATE.
Donati F; Di Giacomo G; Ziranu A; Spinelli S; Perisano C; Rosa MA; Maccauro G
J Biol Regul Homeost Agents; 2015; 29(4 Suppl):149-55. PubMed ID: 26652484
[TBL] [Abstract][Full Text] [Related]
9. Treatment of pathologic fractures of the proximal femur.
Angelini A; Trovarelli G; Berizzi A; Pala E; Breda A; Maraldi M; Ruggieri P
Injury; 2018 Nov; 49 Suppl 3():S77-S83. PubMed ID: 30415673
[TBL] [Abstract][Full Text] [Related]
10. What Are the Long-term Results of MUTARS
Bus MP; van de Sande MA; Fiocco M; Schaap GR; Bramer JA; Dijkstra PD
Clin Orthop Relat Res; 2017 Mar; 475(3):708-718. PubMed ID: 26649558
[TBL] [Abstract][Full Text] [Related]
11. Are Complications Associated With the Repiphysis(®) Expandable Distal Femoral Prosthesis Acceptable for Its Continued Use?
Staals EL; Colangeli M; Ali N; Casanova JM; Donati DM; Manfrini M
Clin Orthop Relat Res; 2015 Sep; 473(9):3003-13. PubMed ID: 25995179
[TBL] [Abstract][Full Text] [Related]
12. Implant and limb survival after resection of primary bone tumors of the lower extremities and reconstruction with mega-prostheses fifty patients followed for a mean of forteen years.
Holm CE; Bardram C; Riecke AF; Horstmann P; Petersen MM
Int Orthop; 2018 May; 42(5):1175-1181. PubMed ID: 29532112
[TBL] [Abstract][Full Text] [Related]
13. A long-term experience with Mutars tumor megaprostheses: analysis of 187 cases.
Pala E; Trovarelli G; Ippolito V; Berizzi A; Ruggieri P
Eur J Trauma Emerg Surg; 2022 Jun; 48(3):2483-2491. PubMed ID: 34727192
[TBL] [Abstract][Full Text] [Related]
14. Silver-coated (Agluna®) tumour prostheses can be a protective factor against infection in high risk failure patients.
Parry MC; Laitinen MK; Albergo JI; Gaston CL; Stevenson JD; Grimer RJ; Jeys LM
Eur J Surg Oncol; 2019 Apr; 45(4):704-710. PubMed ID: 30591310
[TBL] [Abstract][Full Text] [Related]
15. [Surgical treatment of giant cell tumors with pathological fracture around the knee].
Liu WF; Yang FJ; Li Y; Li B; Hao L; Niu XH
Zhonghua Wai Ke Za Zhi; 2018 Sep; 56(9):677-686. PubMed ID: 30157574
[No Abstract] [Full Text] [Related]
16. Modular endoprosthetic replacement for tumours of the proximal femur.
Chandrasekar CR; Grimer RJ; Carter SR; Tillman RM; Abudu A; Buckley L
J Bone Joint Surg Br; 2009 Jan; 91(1):108-12. PubMed ID: 19092014
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of failure and survival of total femoral endoprosthetic replacements.
Medellin MR; Fujiwara T; Clark R; Stevenson JD; Parry M; Jeys L
Bone Joint J; 2019 May; 101-B(5):522-528. PubMed ID: 31038993
[TBL] [Abstract][Full Text] [Related]
18. [Endoprosthetic reconstruction after wide resection of sarcoma in lower extremities].
Guo W; Ji T; Yant Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):970-4. PubMed ID: 17140065
[TBL] [Abstract][Full Text] [Related]
19. Reconstruction of lower extremity primary malignant and metastatic bone tumours with modular endoprosthesis.
Sezgin H; Çıraklı A; Göçer H; Dabak N
Niger J Clin Pract; 2017 Sep; 20(9):1127-1132. PubMed ID: 29072235
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: a retrospective, comparative study.
Larena-Avellaneda A; Russmann S; Fein M; Debus ES
J Vasc Surg; 2009 Oct; 50(4):790-8. PubMed ID: 19660894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
